Balcerac, Alexander
Bihan, Kevin
Lebrun-Vignes, Bénédicte
Thabut, Dominique
Salem, Joe-Elie
Weiss, Nicolas http://orcid.org/0000-0001-5155-196X
Funding for this research was provided by:
SRLF voucher (TC00845191)
Article History
Received: 14 January 2022
Accepted: 29 May 2022
First Online: 18 June 2022
Declarations
:
: Not applicable.
: Not applicable. NCT number: 03947034, AmmoTOX.
: Nicolas Weiss declares having received consultant fees from MedDay Pharmaceuticals and Owkin. Dominique Thabut declares having received consultant fees from MedDay Pharmaceuticals and Alfasigma. Joe-Elie Salem, Kevin Bihan, Bénédicte Lebrun-Vigne and Alexander Balcerac have nothing to disclose.